NCT01873716View on ClinicalTrials.gov

Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
AtherosclerosisAtherosclerotic PlaqueCarotid Stenosis
Interventions
DRUG

Indocyanine green

Indocyanine green (ICG) for injection, 0.25mg/kg intravenously. A maximum of 25mg is given, approximately 30-60 minutes before carotid endarterectomy

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01873716 - Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque | Biotech Hunter | Biotech Hunter